Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

133
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
133
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

452
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
452
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-dose modified-release formulation of a poorly soluble drug via twin-screw melt coating and granulation.

International journal of pharmaceutics·2024
Same author

Industry Perspective - What does Industry Need to Accelerate Drug Product and Process Development?

Pharmaceutical research·2023
Same author

Multi-layer Raman chemical mapping to investigate the effect of API particle size and blending shear rate on API domain sizes in pharmaceutical tablets.

International journal of pharmaceutics·2022
Same author

Integrating sensors for monitoring blend content in a pharmaceutical continuous manufacturing plant.

International journal of pharmaceutics·2021
Same author

Prediction of tablet weight variability in continuous manufacturing.

International journal of pharmaceutics·2019
Same author

Mixing Cell: a Device to Mimic Extent of Lubrication and Shear in Continuous Tubular Blenders.

AAPS PharmSciTech·2019

Related Experiment Video

Updated: Jun 27, 2025

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

3.3K

Accelerating Process Development and Product Formulation.

Mauricio Futran1, Fernando Muzzio2, Bikash Chatterjee3

  • 1Pharmaceutical Engineering Solutions, LLC, Westfield, NJ, USA. mfutran@gmail.com.

Pharmaceutical Research
|May 2, 2024
PubMed
Summary

New technologies and adaptive development can accelerate drug approval timelines, improving patient access to medications and emergency treatments. Collaboration and regulatory shifts are crucial for faster drug development.

Keywords:
NIPTEadaptive developmentadvanced manufacturingcontinuous manufacturingpredictive modelling

More Related Videos

Research and Development of High-performance Explosives
10:33

Research and Development of High-performance Explosives

Published on: February 20, 2016

17.6K
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.3K

Related Experiment Videos

Last Updated: Jun 27, 2025

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

3.3K
Research and Development of High-performance Explosives
10:33

Research and Development of High-performance Explosives

Published on: February 20, 2016

17.6K
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.3K

Area of Science:

  • Pharmaceutical Sciences
  • Drug Development
  • Regulatory Science

Background:

  • Lengthy drug development and approval processes delay patient access to new medications.
  • Slow response times to public health emergencies requiring novel treatments.
  • Current drug formulation and process development face significant acceleration barriers.

Purpose of the Study:

  • To explore opportunities for accelerating drug product development and approval timelines.
  • To identify barriers hindering faster drug development and propose solutions.
  • To share perspectives on overcoming development hurdles using new technologies.

Main Methods:

  • Analysis of discussions from the January 2023 NIPTE pathfinding workshop.
  • Review of current product formulation and process development.
  • Identification of advanced manufacturing techniques and adaptive development strategies.

Main Results:

  • New technologies offer potential solutions to accelerate drug development.
  • Advanced manufacturing and adaptive development are key strategies for acceleration.
  • Paradigm shifts in regulatory processes are necessary.

Conclusions:

  • Accelerating drug development requires technological innovation and adaptive strategies.
  • Increased pre-competitive collaboration among regulators, industry, and academia is essential.
  • A shared strategy is needed to overcome barriers in drug development and approval.